Drug
Propofol (Group P)
Propofol (Group P) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction
NCT07303985
completedphase_4
Effect of Desflurane v/s Propofol on the Optic Nerve Sheath Diameter
NCT07359508
completedphase_4
The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy
NCT02952222
Clinical Trials (3)
Showing 3 of 3 trials
NCT07303985Phase 3
The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction
NCT07359508Phase 4
Effect of Desflurane v/s Propofol on the Optic Nerve Sheath Diameter
NCT02952222Phase 4
The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3